[C.elegansII] Deleted in Bergerac strains; no apparent phenotype. Encodes glyceraldehyde-3-phosphate-dehydrogenase, major muscle-specific isozyme(GAPDHase-2), expression increases postembryonically. Final gene in operon with mai-1, gpd-2. [Barrios et al. 1989; Spieth et al. 1993; HH; BL]
Predicted to enable glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity. Predicted to be involved in glycolytic process. Predicted to be located in cytosol. Expressed in several structures, including gonad; intestine; and pharynx. Human ortholog(s) of this gene implicated in Alzheimer's disease and lymphangioleiomyomatosis. Is an ortholog of human GAPDH (glyceraldehyde-3-phosphate dehydrogenase).
Map position created from combination of previous interpolated map position (based on known location of sequence) and allele information. Therefore this is not a genetic map position based on recombination frequencies or genetic experiments. This was done on advice of the CGC.